For citations:

Zyryanov S.K., Dyakov I.N. The economic side of an oral sugar lowering therapy intensification by glucagon-like peptidt-1 receptor agonists. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2021;(4):4-15. (In Russ.) https://doi.org/10.37489/2588-0519-2021-4-15